Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M701327200 on May 22, 2007

J. Biol. Chem., Vol. 282, Issue 28, 20264-20272, July 13, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/28/20264    most recent
M701327200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varfaj, F.
Right arrow Articles by Fay, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varfaj, F.
Right arrow Articles by Fay, P. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Residues Surrounding Arg336 and Arg562 Contribute to the Disparate Rates of Proteolysis of Factor VIIIa Catalyzed by Activated Protein C*

Fatbardha Varfaj1, Hironao Wakabayashi, and Philip J. Fay2

From the Department of Biochemistry and Biophysics, University of Rochester School of Medicine, Rochester, New York 14642

Activated Protein C (APC) inactivates factor VIIIa by cleavage at Arg336 and Arg562 within the A1 and A2 subunits, respectively, with reaction at the former site occurring at a rate ~25-fold faster than the latter. Recombinant factor VIII variants possessing mutations within the P4-P3' sequences were used to determine the contributions of these residues to the disparate cleavage rates at the two P1 sites. Specific activity values for 336(P4-P3')562, 336(P4-P2)562, and 336(P1'-P3')562 mutants, where indicated residues surrounding the Arg336 site were replaced with those surrounding Arg562, were similar to wild type (WT) factor VIII; whereas 562(P4-P3')336 and 562(P4-P2)336 mutants showed specific activity values <1% the WT value. Inactivation rates for the 336 site mutants were reduced ~6–11-fold compared with WT factor VIIIa, and approached values attributed to cleavage at Arg562. Cleavage rates at Arg336 were reduced ~100-fold for 336(P4-P3')562, and ~9–16-fold for 336(P4-P2)562 and 336(P1'-P3')562 mutants. Inhibition kinetics revealed similar affinities of APC for WT factor VIIIa and 336(P4-P3')562 variant. Alternatively, the 562(P4-P3')336 variant showed a modest increase in cleavage rate (~4-fold) at Arg562 compared with WT, whereas these rates were increased by ~27- and 6-fold for 562(P4-P3')336 and 562(P4-P2)336, respectively, using the factor VIII procofactor form as substrate. Thus the P4-P3' residues surrounding Arg336 and Arg562 make significant contributions to proteolysis rates at each site, apparently independent of binding affinity. Efficient cleavage at Arg336 by APC is attributed to favorable P4-P3' residues at this site, whereas cleavage at Arg562 can be accelerated following replacement with more optimal P4-P3' residues.


Received for publication, February 15, 2007 , and in revised form, April 17, 2007.

* This work was supported in part by National Institutes of Health Grants HL76213 and HL38199. An account of this work was presented at the 48th annual meeting of the American Society of Hematology, Orlando, FL, December 9, 2006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by an American Heart Association predoctoral fellowship.

2 To whom correspondence should be addressed: P. O. Box 712, University of Rochester School of Medicine, 601 Elmwood Ave., Rochester, NY 14642. Tel.: 585-275-6576; Fax: 585-275-6007; E-mail: philip_fay{at}urmc.rochester.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement